TIRZEPATIDE MEDICATION
SUSTAINABLE MEDICAL WEIGHT LOSS & GLUCOSE CONTROL
Discover the Power of Tirzepatide for
Experience the power of Tirzepatide in enhancing glucose control and supporting healthy weight management. As a GIP and GLP-1 receptor agonist, Tirzepatide offers a comprehensive approach to managing type 2 diabetes and weight loss. Clinical studies have demonstrated its ability to reduce HbA1c levels and body weight, making it an exciting option for individuals looking to take control of their diabetes management and achieve lasting weight loss.
ABOUT TIRZEPATIDE
Tirzepatide is the second most common medication prescribe at our practice. See the list of information and details below on this medication and its uses.
- Tirzepatide (Mounjoro) is a powerful new type 2 diabetes drug shown to be extremely effective for weight loss. It was recently approved for diabetes and is awaiting FDA approval for the primary treatment of obesity. It is a dual incretin agonist or a “twincreatin” that acts on TWO hunger hormone receptors: GIP and GLP-1.
In a press release from Eli Lilly in April of 2022, “GIP is a hormone that may complement the effects of GLP-1 receptor agonists. In preclinical models, GIP has been shown to decrease food intake and increase energy expenditure therefore resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose, and lipids.”
- Data from the first and largest of Lilly’s pivotal trials showed participants taking Tirzepatide lost as much as 25 pounds on average over 40 weeks (with additional lifestyle modifications). Those who continued beyond 40 weeks, lost as much as 52 pounds! The average weight loss with Tirzepatide is an astonishing 22.5%.
We can offer a compounded version of Tirzepatide that also contains added Vitamin B12. The side effects of Tirzepatide are like GLP-1 medications and includes nausea and gastrointestinal disturbance. Most side effects are brief when the medication is started at the lowest dose and slowly increased over time. Like Semaglutide, the medication is taken as a once-a-week nearly painless injection.
HOW IT WORKS
Our Medically Supervised Weight Loss Program utilizes a weekly injectable medication to assist with weight loss. The two medications used most often in our practice are Semaglutide (brand named Wegovy or Ozempic) and Tirzepatide (brand name Mounjoro).
